Search results
Novelis Postpones Over $900 Million U.S. IPO
The Wall Street Journal· 17 hours agoS. listing of over $900 million, citing market conditions. “Novelis will continue to evaluate the timing of the offering in the future,” the company said...
Nio Stock Dips With Earnings Due And Startup EV Rival Zeekr In IPO Base
Investor's Business Daily· 9 minutes agoThe Nio earnings report comes as market watchers point to several sales tail winds ahead. Its EV...
Where Humana lands on this year's Fortune 500 list - Louisville Business First
The Business Journals· 2 hours agoIn total, Fortune 500 companies represent two-thirds of the U.S. GDP with $18.8 trillion in...
Radiopharma-focused Telix heats up IPO summer market with $200M offering
FierceBiotech· 5 hours agoAustralian radiopharmaceuticals biotech Telix Pharmaceuticals is targeting a $200 million initial...
Hindalco-owned Novelis delays US IPO; shares slide
Reuters via Yahoo Finance· 18 hours agoBENGALURU (Reuters) -Hindalco Industries said on Wednesday its U.S-based unit Novelis has postponed its initial public offering (IPO) ...
Dow Jones Falls As Warren Buffett Stock 'Plunges' 99%; Bill Ackman Makes This IPO Move
Investor's Business Daily· 2 days ago"The economy is, in the U.S., quite strong, the labor market is strong, inflation is coming down and...
Wall Street's New Favorites: 3 Stocks Analysts Are Raving About in May
InvestorPlace· 7 days agoThe initial public offering (IPO) market is officially back, featuring several analyst favorite...
Palantir Wins Defense Department AI Contract Worth Up to $633M
Market Watch· 6 days agoThe data-analytics firm also said on Thursday it has received a $33 million deal to securely onboard third-party vendor and government capabilities into the government-owned, Palantir-operated ...
European IPO Market Roars Back to Life: A Promising Start to 2024
Morningstar· 2 days agoSINGAPORE, SINGAPORE / ACCESSWIRE / June 3, 2024 / The IPO market has roared back to life in 2024, showcasing its strongest start since the 2021 boom. High-profile ...
J&J-backed Rapport Therapeutics seeks about $637 million valuation in US IPO
Reuters via Yahoo News· 2 days agoThe U.S. IPO market is staging a strong comeback after two dismal years, thanks to a rally in the stock market ...
